Market by Mechanism, Indicator, Consumer, Commodity, and Country Outlook | Forecast 2022-2028
Based on Triton Market Research’s estimates, the companion diagnostics market in Middle East and Africa is set to witness revenue growth at a CAGR of 12.53% during the forecasted years 2022-2028.
Report scope can be customized per your requirements. Request For CustomizationÂ
The
countries evaluated in the region comprise:
•       Â
The United Arab Emirates
•        Israel
•       Â
Saudi Arabia
•       Â
Turkey
•       Â
South Africa
•       Â
Rest of Middle East & Africa
Turkey secures the majority of the
shares in the Middle East and Africa. In the region, the healthcare
demand has soared significantly over the past years. In this regard, a surge in
cancer cases and other genetic diseases have compelled governments to invest
heavily in the healthcare sector. Additionally, the rising awareness pertaining
to genetic screening to help determine drug efficacy is anticipated to
encourage manufacturers to develop companion diagnostics devices. Thus, as
stated above, these factors are likely to create affluent opportunities for the
market.
Turkey’s
robust growth can be attributed to the rise in partnerships between government,
regulatory agencies, and pharmaceutical companies. Along with this, the
implementation of strong laws, economic conditions, and government initiatives
are fueling the adoption of companion diagnostics devices. The rising focus on
precision medicine is also expected to expand the healthcare sector, elevating
the demand for companion diagnostics technology.
In
Saudi Arabia, the medical device and in-vitro diagnostics are primarily based
on requirements set forth by International Medical Device Regulators Forum and
Global Harmonization Task Force. The marketing of these devices is approved by
these organizations. Given the guidelines, Biocartis and Amgen collaborated to
increase access to RAS biomarker information for metastatic colorectal cancer.
Such initiatives create numerous opportunities for the companion diagnostics
market.
Companion
diagnostics support the precise diagnosis of infectious diseases in humans.
Moreover, it helps researchers develop precision medicines for quick treatment
and recovery. The infectious disease field includes zoonotic diseases, and vector-borne
diseases like smallpox, measles, etc. The
market report is segmented into indicator, commodity, mechanism, and consumer.
The indicator section is categorized into infectious disease, oncology,
neurology, and other indicators.
Almac Group, Biocartis, Danaher
Corporation, Genomic Health, Illumina Inc, Myriad Genetics, and Arup
Laboratories are among the leading companies in the companion diagnostics
market.
Biocartis
is a commercial-stage molecular diagnostics company that develops next
generation diagnostic solutions. Its product line includes diagnostic tools,
advanced analyses, and a technology platform to detect bio-analyses used in
various applications. The company has expanded its research and development
initiatives in the oncology and infectious disease fields, witnessing a rise in
sales. Biocartis serves clients across numerous regions, including the Middle
East and Africa.
Â
Key deliverables of the report:
·      Market CAGR during the forecasting
years 2022-2028
·      Detailed data highlighting key insights,
industry components, and market strategies
·   Comprehensive information and
estimation of the companion diagnostics market revenue growth in the Middle
East and Africa and its influence on the parent market
·      In-depth study of forthcoming trends
in consumer behavioral patterns
·      A meticulous analysis of the
competitive landscape, vendor scorecard, and Porter’s Five Forces
·    A wide-ranging study of factors that
will challenge the Middle East and Africa companion diagnostics market’s growth
during the upcoming years
Want
to get specific insights? Our team of analysts can customize this report based
on your preferences. Connect with us here.Â
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. MIDDLE
EAST AND AFRICA COMPANION DIAGNOSTICS MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE COMPANION DIAGNOSTICS MARKET
2.2. KEY
INSIGHTS
2.2.1. COMMERCIAL
SUCCESS OF PRECISION MEDICINE TREATMENT
2.2.2. ADOPTION
OF PREDICTIVE BIOMARKERS
2.2.3. FUSION
OF COMPUTER SCIENCE AND BIOLOGY
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. KEY
BUYING IMPACT ANALYSIS
2.4.1. COST
2.4.2. AVAILABILITY
2.4.3. SENSITIVITY
& SPECIFICITY
2.4.4. EFFICACY
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. VENDOR
SCORECARD
2.7. INDUSTRY
COMPONENTS
2.8. REGULATORY
FRAMEWORK
2.9. KEY
MARKET STRATEGIES
2.9.1. ACQUISITIONS
2.9.2. PRODUCT
LAUNCHES
2.9.3. CONTRACTS
& AGREEMENTS
2.10. MARKET
DRIVERS
2.10.1. INCREASE
IN INCIDENCE OF MEDICATION REACTIONS
2.10.2. INCREASING
PREVALENCE OF CANCER CASES AND FATALITIES
2.10.3. RISING
PREVALENCE OF PRECISION MEDICINES
2.11. MARKET
CHALLENGES
2.11.1. WEAK
REIMBURSEMENT FRAMEWORK
2.11.2. COMMON
CASES OF LEAKAGE IN ONCOLOGY COMPANION DIAGNOSTICS
2.12. MARKET
OPPORTUNITY
2.12.1. ONGOING
RESEARCH AND INVESTMENTS IN NEXT GENERATION GENE-SEQUENCING
3. MIDDLE
EAST AND AFRICA COMPANION DIAGNOSTICS MARKET OUTLOOK - BY MECHANISM
3.1. IN-SITU
HYBRIDIZATION
3.2. POLYMERASE
CHAIN REACTION
3.3. IMMUNOHISTOCHEMISTRY
3.4. NEXT
GENERATION SEQUENCING
3.5. OTHER
MECHANISMS
4. MIDDLE
EAST AND AFRICA COMPANION DIAGNOSTICS MARKET OUTLOOK - BY INDICATOR
4.1. ONCOLOGY
4.2. NEUROLOGY
4.3. INFECTIOUS
DISEASES
4.4. OTHER
INDICATORS
5. MIDDLE
EAST AND AFRICA COMPANION DIAGNOSTICS MARKET OUTLOOK - BY CONSUMER
5.1. PHARMACEUTICAL
AND BIOPHARMACEUTICAL COMPANIES
5.2. REFERENCE
LABORATORIES
5.3. OTHER
CONSUMERS
6. MIDDLE
EAST AND AFRICA COMPANION DIAGNOSTICS MARKET OUTLOOK - BY COMMODITY
6.1. ASSAY
KITS AND REAGENTS
6.2. SOFTWARE
AND SERVICES
7. MIDDLE
EAST AND AFRICA COMPANION DIAGNOSTICS MARKET - COUNTRY OUTLOOK
7.1. UNITED
ARAB EMIRATES
7.2. SAUDI
ARABIA
7.3. TURKEY
7.4. SOUTH
AFRICA
7.5. REST
OF MIDDLE EAST & AFRICA
8. COMPETITIVE
LANDSCAPE
8.1. ABBOTT
LABORATORIES
8.2. ALMAC
GROUP
8.3. ARUP
LABORATORIES
8.4. BIOCARTIS
8.5. BIOMERIEUX
8.6. DANAHER
CORPORATION
8.7. GE
HEALTHCARE
8.8. GENOMIC
HEALTH
8.9. ILLUMINA
INC
8.10. MYRIAD
GENETICS
8.11. QIAGEN
8.12. ROCHE
DIAGNOSTICS
8.13. SYSMEX
CORPORATION
8.14. THERMO
FISHER SCIENTIFIC
8.15. AGILENT
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.2. SOURCES
OF DATA
9.3. RESEARCH
METHODOLOGY
TABLE 1: MIDDLE EAST AND
AFRICA COMPANION DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LIST OF ACQUISITIONS
TABLE 4: LIST OF PRODUCT
LAUNCHES
TABLE 5: LIST OF CONTRACTS
& AGREEMENTS
TABLE 6: NUMBER OF CANCER
PATIENTS IN 2020
TABLE 7: MIDDLE EAST AND
AFRICA COMPANION DIAGNOSTICS MARKET, OUTLOOK BY MECHANISM, 2022-2028 (IN $
MILLION)
TABLE 8: MIDDLE EAST AND
AFRICA COMPANION DIAGNOSTICS MARKET, OUTLOOK BY INDICATOR, 2022-2028 (IN $
MILLION)
TABLE 9: MIDDLE EAST AND
AFRICA COMPANION DIAGNOSTICS MARKET, OUTLOOK BY CONSUMER, 2022-2028 (IN $
MILLION)
TABLE 10: MIDDLE EAST AND
AFRICA COMPANION DIAGNOSTICS MARKET, OUTLOOK BY COMMODITY, 2022-2028 (IN $
MILLION)
TABLE 11: MIDDLE EAST AND
AFRICA COMPANION DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
FIGURE 1: MARKET
ATTRACTIVENESS INDEX
FIGURE 2: INDUSTRY COMPONENTS
FIGURE 3: FDA FRAMEWORK
FIGURE 4: CDX LEAKAGE POINTS
FIGURE 5: MIDDLE EAST AND
AFRICA COMPANION DIAGNOSTICS MARKET, OUTLOOK BY MECHANISM, 2021 & 2028 (IN
%)
FIGURE 6: MIDDLE EAST AND
AFRICA COMPANION DIAGNOSTICS MARKET, BY IN-SITU HYBRIDIZATION, 2022-2028 (IN $
MILLION)
FIGURE 7: MIDDLE EAST AND
AFRICA COMPANION DIAGNOSTICS MARKET, BY POLYMERASE CHAIN REACTION, 2022-2028
(IN $ MILLION)
FIGURE 8: MIDDLE EAST AND
AFRICA COMPANION DIAGNOSTICS MARKET, BY IMMUNOHISTOCHEMISTRY, 2022-2028 (IN $
MILLION)
FIGURE 9: MIDDLE EAST AND
AFRICA COMPANION DIAGNOSTICS MARKET, BY NEXT GENERATION SEQUENCING, 2022-2028
(IN $ MILLION)
FIGURE 10: MIDDLE EAST AND
AFRICA COMPANION DIAGNOSTICS MARKET, BY OTHER MECHANISMS, 2022-2028 (IN $
MILLION)
FIGURE 11: MIDDLE EAST AND
AFRICA COMPANION DIAGNOSTICS MARKET, OUTLOOK BY INDICATOR, 2021 & 2028 (IN
%)
FIGURE 12: MIDDLE EAST AND
AFRICA COMPANION DIAGNOSTICS MARKET, BY ONCOLOGY, 2022-2028 (IN $ MILLION)
FIGURE 13: MIDDLE EAST AND
AFRICA COMPANION DIAGNOSTICS MARKET, BY NEUROLOGY, 2022-2028 (IN $ MILLION)
FIGURE 14: MIDDLE EAST AND
AFRICA COMPANION DIAGNOSTICS MARKET, BY INFECTIOUS DISEASES, 2022-2028 (IN $
MILLION)
FIGURE 15: MIDDLE EAST AND
AFRICA COMPANION DIAGNOSTICS MARKET, BY OTHER INDICATORS, 2022-2028 (IN $
MILLION)
FIGURE 16: MIDDLE EAST AND
AFRICA COMPANION DIAGNOSTICS MARKET, OUTLOOK BY CONSUMER, 2021 & 2028 (IN
%)
FIGURE 17: MIDDLE EAST AND
AFRICA COMPANION DIAGNOSTICS MARKET, BY PHARMACEUTICAL AND BIOPHARMACEUTICAL
COMPANIES, 2022-2028 (IN $ MILLION)
FIGURE 18: MIDDLE EAST AND
AFRICA COMPANION DIAGNOSTICS MARKET, BY REFERENCE LABORATORIES, 2022-2028 (IN $
MILLION)
FIGURE 19: MIDDLE EAST AND
AFRICA COMPANION DIAGNOSTICS MARKET, BY OTHER CONSUMERS, 2022-2028 (IN $
MILLION)
FIGURE 20: MIDDLE EAST AND
AFRICA COMPANION DIAGNOSTICS MARKET, OUTLOOK BY COMMODITY, 2021 & 2028 (IN
%)
FIGURE 21: MIDDLE EAST AND
AFRICA COMPANION DIAGNOSTICS MARKET, BY ASSAY KITS AND REAGENTS, 2022-2028 (IN
$ MILLION)
FIGURE 22: MIDDLE EAST AND
AFRICA COMPANION DIAGNOSTICS MARKET, BY SOFTWARE AND SERVICES, 2022-2028 (IN $
MILLION)
FIGURE 23: MIDDLE EAST AND
AFRICA COMPANION DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 24: UNITED ARAB
EMIRATES COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 25: SAUDI ARABIA
COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 26: TURKEY COMPANION
DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 27: SOUTH AFRICA
COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 28: REST OF MIDDLE EAST
& AFRICA COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)